Skip to main content

letter

. 1979 Sep 8;2(6190):612–613. doi: 10.1136/bmj.2.6190.612-c

Reversible renal failure during treatment with captopril.

P Collste, K Haglund, G Lundgren, G Magnusson, J Ostman

PMCID: PMC1596482 PMID: 387174

612

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Atkinson A. B., Brown J. J., Fraser R., Leckie B., Lever A. F., Morton J. J., Robertson J. I. Captopril, angiotensin II, and sodium in blood-pressure regulation. Lancet. 1979 May 26;1(8126):1140–1140. [PubMed] [Google Scholar]
Atkinson A. B., Brown J. J., Morton J. J., Leckie B., Fraser R., Lever A. F., Robertson J. I. Captopril in a hyponatraemic hypertensive: need for caution in initiating therapy. Lancet. 1979 Mar 10;1(8115):557–558. doi: 10.1016/s0140-6736(79)90983-8. [DOI] [PubMed] [Google Scholar]
Bravo E. L., Tarazi R. C. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension. 1979 Jan-Feb;1(1):39–46. doi: 10.1161/01.hyp.1.1.39. [DOI] [PubMed] [Google Scholar]
Brunner H. R., Waeber B., Gavras H. Rational use of captopril. Lancet. 1979 Apr 14;1(8120):832–832. doi: 10.1016/s0140-6736(79)91358-8. [DOI] [PubMed] [Google Scholar]
Duhme D. W., Sancho J., Athanasoulis C., Haber E., Koch-Weser J. Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881. Lancet. 1974 Mar 9;1(7854):408–408. doi: 10.1016/s0140-6736(74)93173-0. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES